tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of James Quigley, 33 are a HOLD (55%), 4 are a SELL (6.67%), 23 are a BUY (38.33%).
Analyst James Quigley, currently employed at GOLDMAN SACHS, carries an average stock price target met ratio of 53.13% that have a potential upside of 16.68% achieved within 199 days. Previously, James Quigley worked at JPMORGAN, BERENBERG, MORGAN STANLEY.
James Quigley’s has documented 111 price targets and ratings displayed on 9 stocks. The coverage is on Healthcare, Consumer Defensive sectors.
Most recent stock forecast was given on NVO, Novo Nordisk A/S at 02-Mar-2026.
Analyst best performing recommendations are on KYMR (KYMERA THERAPEUTICS).
The best stock recommendation documented was for GLPG (GALAPAGOS NV ADR) at 8/7/2023. The price target of $40 was fulfilled within 1 day with a profit of $0.43 (1.06%) receiving and performance score of 10.64.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 16-Jun-2023
$17
$-1.96 (-10.34%)
$17
2 years 8 months 4 days ago
(05-Feb-2024)
3/3 (100%)
$-0.27 (-1.56%)
96
Buy Since 16-Jan-2024
2 years 8 months 20 days ago
(19-Jan-2024)
4/7 (57.14%)
$2.7 (41.54%)
490
Buy Since 05-Dec-2023
$8.5
$-10.46 (-55.17%)
$10
2 years 10 months 4 days ago
(05-Dec-2023)
3/4 (75%)
$0.92 (12.14%)
253
Buy Since 05-Dec-2023
$8.5
$-10.46 (-55.17%)
$10
2 years 10 months 4 days ago
(05-Dec-2023)
2/3 (66.67%)
$0.92 (12.14%)
106
Hold
$4.75
$-13.1 (-73.39%)
2 years 10 months 17 days ago
(22-Nov-2023)
1/2 (50%)
$0.2 (4.40%)
5
What Year was the first public recommendation made by James Quigley?
